Traub Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$542K Sell
8,678
-1,550
-15% -$98K 0.47% 50
2026
Q2
$589K Hold
10,228
– – 0.53% 47
2026
Q1
$620K Hold
10,228
– – 0.62% 44
2025
Q4
$552K Buy
10,228
+200
+2% +$9.6K 0.53% 51
2025
Q3
$452K Buy
10,028
+2,474
+33% +$116K 0.45% 61
2025
Q2
$350K Buy
+7,554
New +$371K 0.32% 70

Other funds holding BMY

Traub Capital Management's BMY Position: Q3 2026 in Review

Traub Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 15% in Q3 2026, selling an estimated $98K and leaving 8,678 shares worth $542K. The position accounts for 0.47% of the portfolio, ranked #50.

Traub Capital Management first reported a position in BMY in Q2 2025 and has held it in 6 quarters since. The position peaked at $620K in Q1 2026. 2,556 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Traub Capital Management held 8,678 shares of Bristol-Myers Squibb worth $542K as of Q3 2026.
  • Traub Capital Management sold 1,550 Bristol-Myers Squibb shares in Q3 2026, an estimated $98K.
  • Bristol-Myers Squibb made up 0.47% of Traub Capital Management's portfolio in Q3 2026, its #50 holding.
  • Traub Capital Management first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 6 quarters since.
  • Traub Capital Management's Bristol-Myers Squibb position peaked at $620K in Q1 2026.
  • 2,556 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Traub Capital Management's 13F filing for Q3 2026, filed 9 Nov 2026.